Myeloma Rounds Durham
May 8, 2024
Format
New Live, In-Person Event
*Pre-registration required
Live interactive continuing medical education activity for healthcare professionals in Chapel Hill, Charlotte, Durham, Raleigh, Winston-Salem, and surrounding areas to discuss multiple myeloma updates and challenges in treatment.
Target Audience
This activity in intended for hematologists-oncologists, medical oncologists, physician associates, advanced practice providers, nurses and pharmacists involved in the care of patients with myeloma.
Agenda
5:30 PM – Dinner and Networking
6:30 PM – Welcome and Overview of LLS Resources
Cindy Varga, MD and Lauren Berger, MPH
6:37 PM – Updates in Multiple Myeloma Clinical Research in 2024
Cristiana Costa Chase, DO
6:50 PM – Case Presentation on Transplant Considerations in Amyloidosis and Discussion*
John Mckay, DO
7:20 PM – Case Presentation on Clonal Hematopoiesis in Patients Receiving Chimeric Antigen Receptor T-cell Therapy and Discussion*
Cindy Varga, MD
7:50 PM – Case Presentation on MRD Testing and Discussion*
Eben Lichtman, MD
8:20 PM – Discussion and Wrap-up
All Faculty
8:30 PM – Conclusion
*Additional discussants: Drs. Gasparetto, Kang, and Voorhees
Educational Objectives
At the conclusion of this activity, participants will be better able to:
- Describe the latest developments in myeloma, including current and emerging treatments
- Engage patients and caregivers in discussions on clinical trials, newly approved therapies and emerging therapies for myeloma, including combination therapies, CAR T-cell therapy and bispecific antibodies
- Identify disparities and challenges in diagnosis and treatment of myeloma
- Apply evidence-based treatment strategies for optimal patient care
- Access patient support resources
Advisory Group
Cindy Varga, MD (Chair)
Levine Cancer Institute
Atrium Health
Charlotte, NC
Cristiana Costa Chase, DO
Duke Blood Cancer Center
Duke University Medical Center
Durham, NC
Grace Elsey, PharmD, BCOP
Levine Cancer Institute
Atrium Health
Charlotte, NC
Eben Lichtman, MD
Lineberger Comprehensive Cancer Center
University of North Carolina
Chapel Hill, NC
John Mckay, DO
Wake Forest Baptist
Atrium Health
Winston-Salem, NC
Faculty
Cindy Varga, MD (Chair)
Levine Cancer Institute
Atrium Health
Charlotte, NC
Lauren Berger, MPH
The Leukemia & Lymphoma Society
Rye Brook, NY
Cristiana Costa Chase, DO
Duke Blood Cancer Center
Duke University Medical Center
Durham, NC
Eben Lichtman, MD
Lineberger Comprehensive Cancer Center
University of North Carolina
Chapel Hill, NC
John Mckay, DO
Wake Forest Baptist
Atrium Health
Winston-Salem, NC
Guest Discussants: Cristina Gasparetto, MD, Yubin Kang, MD, and Peter Voorhees, MD
Continuing Education Information
Accreditation, Credit and Support
In support of improving patient care, this activity has been planned and implemented by Medical Learning Institute, Inc. and The Leukemia & Lymphoma Society. Medical Learning Institute, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Medical Education
Medical Learning Institute, Inc. (MLI) designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credits™.
Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physician Associate
Medical Learning Institute, Inc. has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 2.0 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
Nursing Continuing Professional Development Contact Hours
Approval for nurses has been obtained by the National Office of The Leukemia & Lymphoma Society under Provider Number CEP 5832 to award 2.0 continuing education contact hour through the California Board of Registered Nursing.
Continuing Pharmacy Education
Medical Learning Institute, Inc. designates this continuing education activity for 2.0 contact hours (0.2 CEUs) of the Accreditation Council for Pharmacy Education.
Universal Activity Number: JA0007322-9999-24-028-L01-P
Type of Activity: Application
Interprofessional Continuing Education Credit
This activity was planned by and for the healthcare team, and learners will receive 2.0 Interprofessional Continuing Education (IPCE) credits for learning and change.
Method of Participation
There are no fees for participating in or receiving credits for this CE activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.
Learners must participate in the entire CE activity, complete, and submit the evaluation form to earn credit. Once submitted, the certificate will be generated. If you have questions regarding the receipt of your certificate, please contact via email at ndane@mlieducation.org.
For Pharmacists, Medical Learning Institute will accept your completed evaluation form for up to 30 days post-activity and will report your participation to the NABP only if you provide your NABP e-Profile number and DOB (MM/DD). Within 6 weeks, you can view your participation record at the NABP website: https://nabp.pharmacy/
Providers
This activity is provided by The Leukemia & Lymphoma Society and Medical Learning Institute, Inc., in collaboration with the Association of Cancer Care Centers™ (ACCC).
Supporters
Supported by an educational grant from Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC.
For questions, concerns, or assistance for people with disabilities or grievances, please contact us at: profeducation@LLS.org.